8-37828946-G-A
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4BS2
The NM_032777.10(ADGRA2):c.397G>A(p.Glu133Lys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000351 in 1,424,772 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032777.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADGRA2 | NM_032777.10 | c.397G>A | p.Glu133Lys | missense_variant | 3/19 | ENST00000412232.3 | NP_116166.9 | |
ADGRA2 | XM_011544481.3 | c.397G>A | p.Glu133Lys | missense_variant | 3/19 | XP_011542783.1 | ||
ADGRA2 | XM_011544482.3 | c.325G>A | p.Glu109Lys | missense_variant | 2/18 | XP_011542784.1 | ||
ADGRA2 | XM_011544483.3 | c.397G>A | p.Glu133Lys | missense_variant | 3/18 | XP_011542785.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADGRA2 | ENST00000412232.3 | c.397G>A | p.Glu133Lys | missense_variant | 3/19 | 1 | NM_032777.10 | ENSP00000406367.2 | ||
ADGRA2 | ENST00000315215.11 | c.397G>A | p.Glu133Lys | missense_variant | 3/16 | 1 | ENSP00000323508.7 | |||
ADGRA2 | ENST00000428068.5 | c.271G>A | p.Glu91Lys | missense_variant | 3/6 | 3 | ENSP00000400860.1 |
Frequencies
GnomAD3 genomes Cov.: 29
GnomAD4 exome AF: 0.00000351 AC: 5AN: 1424772Hom.: 1 Cov.: 31 AF XY: 0.00000425 AC XY: 3AN XY: 706164
GnomAD4 genome Cov.: 29
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 22, 2024 | The c.397G>A (p.E133K) alteration is located in exon 3 (coding exon 3) of the ADGRA2 gene. This alteration results from a G to A substitution at nucleotide position 397, causing the glutamic acid (E) at amino acid position 133 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at